HYDROLYSIS OF IODINE-LABELED URODILATIN AND ANP BY RECOMBINANT NEUTRAL ENDOPEPTIDASE EC.3.4.24.11

被引:15
作者
ABASSI, ZA [1 ]
GOLOMB, E [1 ]
AGBARIA, R [1 ]
ROLLER, PP [1 ]
TATE, J [1 ]
KEISER, HR [1 ]
机构
[1] NCI,MED CHEM LAB,BETHESDA,MD 20892
关键词
ATRIAL NATRIURETIC PEPTIDE; URODILATIN; NEUTRAL ENDOPEPTIDASE; HPLC; PHOSPHORAMIDON; SQ-28,603;
D O I
10.1111/j.1476-5381.1994.tb16194.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Urodilatin is a 32 amino-acid peptide of similar sequence to atrial natriuretic peptide (ANP), with four additional amino-acids at the N-terminus. Although ANP and urodilatin bind to the same receptors with similar affinities, urodilatin is more active than ANP as a natriuretic agent. Previous studies, using neutral endopeptidase EC 3.4.24.11 (NEP) derived from crude membrane preparations, were inconclusive, but suggested that urodilatin was more resistant than ANP to degradation by this enzyme. In the present study, we compared the degradation rates of [I-125]-urodilatin and [I-125]-ANP by pure recombinant NEP (rNEP). 2 Incubation of radioactively labelled ANP with rNEP resulted in a much more rapid degradation of the peptide than that for labelled urodilatin. 3 Both phosphoramidon and SQ-28,603, potent inhibitors of NEP, completely protected both peptides from metabolism by rNEP. 4 The circular dichroism spectra of the two peptides indicate that they are very similar and exist largely in unordered or flexible conformations. 5 These results support the relative resistance of urodilatin to NEP, and indicate that urodilatin may be of use as a therapeutic agent, in conditions in which ANP is ineffective.
引用
收藏
页码:204 / 208
页数:5
相关论文
共 45 条
  • [1] EFFECT OF CONVERTING-ENZYME INHIBITION ON RENAL RESPONSE TO ANF IN RATS WITH EXPERIMENTAL HEART-FAILURE
    ABASSI, Z
    HARAMATI, A
    HOFFMAN, A
    BURNETT, JC
    WINAVER, J
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (01): : R84 - R89
  • [2] ATRIAL-NATRIURETIC-PEPTIDE AND RENAL CGMP IN RATS WITH EXPERIMENTAL HEART-FAILURE
    ABASSI, Z
    BURNETT, JC
    GRUSHKA, E
    HOFFMAN, A
    HARAMATI, A
    WINAVER, J
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (04): : R858 - R864
  • [3] RENAL AND SYSTEMIC EFFECTS OF URODILATIN IN RATS WITH HIGH-OUTPUT HEART-FAILURE
    ABASSI, ZA
    POWELL, JR
    GOLOMB, E
    KEISER, HR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (04): : F615 - F621
  • [4] URODILATIN - A NATRIURETIC PEPTIDE OF RENAL ORIGIN
    ABASSI, ZA
    GOLOMB, E
    KLEIN, H
    KEISER, HR
    [J]. CARDIOVASCULAR DRUG REVIEWS, 1992, 10 (02): : 199 - 210
  • [5] PHARMACOKINETICS OF ANF AND URODILATIN DURING CANF RECEPTOR BLOCKADE AND NEUTRAL ENDOPEPTIDASE INHIBITION
    ABASSI, ZA
    TATE, J
    HUNSBERGER, S
    KLEIN, H
    TRACHEWSKY, D
    KEISER, HR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (05): : E870 - E876
  • [6] CLEARANCE FUNCTION OF TYPE-C RECEPTORS OF ATRIAL NATRIURETIC FACTOR IN RATS
    ALMEIDA, FA
    SUZUKI, M
    SCARBOROUGH, RM
    LEWICKI, JA
    MAACK, T
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (02): : R469 - R475
  • [7] RENAL EFFECTS OF URODILATIN AND ATRIAL-NATRIURETIC-PEPTIDE IN VOLUME EXPANDED CONSCIOUS DOGS
    BESTLE, MH
    BIE, P
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1993, 149 (01): : 77 - 83
  • [8] Booth A G, 1974, Biochem J, V142, P575
  • [9] CARDIORENAL ACTIONS OF NEUTRAL ENDOPEPTIDASE INHIBITION IN EXPERIMENTAL CONGESTIVE HEART-FAILURE
    CAVERO, PG
    MARGULIES, KB
    WINAVER, J
    SEYMOUR, AA
    DELANEY, NG
    BURNETT, JC
    [J]. CIRCULATION, 1990, 82 (01) : 196 - 201
  • [10] INFLUENCE OF C-ANF RECEPTOR AND NEUTRAL ENDOPEPTIDASE ON PHARMACOKINETICS OF ANF IN RATS
    CHIU, PJS
    TETZLOFF, G
    ROMANO, MT
    FOSTER, CJ
    SYBERTZ, EJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (01): : R208 - R216